SECTOR GAMMA AS
Q4 2023 Form 13-F
OSLO
CIK 0001475373
· Institutional investment manager
$412.1M Reported Value Total
Reported value
$412.1M
Quarter over quarter
+7.1%
Holdings
30
Top-10 concentration
58.0%
Filing Structure
Reports holdings for
- Crestline Management LP · File #028-14917 · Q4 2016 – Q2 2017 · declared by one filing
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Janicke Forde
Head of fund operations
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q4 2023 13F record
Q4 2023 13F filing summary
| Period of report | December 31, 2023 |
|---|---|
| Filed | February 05, 2024 |
| Form | 13F-HR |
| Reported value | $412.1M |
| Positions | 30 |
| Change in reported value | +5.3% |
| New positions | 6 |
| Exited positions | 4 |
| Position turnover | 29.4% |
| Top-10 concentration | 58.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 12, 2026
|
40 | $461.0M |
|
Q1 2026 13F
Filed May 7, 2026
|
42 | $423.5M |
|
Q4 2025 13F
Filed Feb 12, 2026
|
36 | $438.7M |
|
Q3 2025 13F
Filed Oct 31, 2025
|
41 | $403.3M |
|
Q2 2025 13F
Filed Jul 31, 2025
|
38 | $305.9M |
|
Q1 2025 13F
Filed May 13, 2025
|
33 | $312.2M |
|
Q4 2024 13F
Filed Feb 11, 2025
|
30 | $290.9M |
|
Q3 2024 13F
Filed Nov 13, 2024
|
29 | $329.6M |
|
Q2 2024 13F
Filed Aug 9, 2024
|
28 | $267.7M |
|
Q1 2024 13F
Filed May 8, 2024
|
28 | $354.8M |
|
Q4 2023 13F
Filed Feb 5, 2024
|
30 | $412.1M |
|
Q3 2023 13F
Filed Nov 6, 2023
|
28 | $391.3M |
|
Q2 2023 13F
Filed Aug 9, 2023
|
29 | $446.9M |
|
Q1 2023 13F
Filed May 12, 2023
|
31 | $412.5M |
|
Q4 2022 13F
Filed Feb 7, 2023
|
31 | $437.4M |
|
Q3 2022 13F
Filed Nov 9, 2022
|
31 | $388.0M |
|
Q2 2022 13F
Filed Aug 5, 2022
|
37 | $447.0M |
|
Q1 2022 13F
Filed May 6, 2022
|
40 | $460.2M |
|
Q4 2021 13F
Filed Feb 8, 2022
|
33 | $425.4M |
|
Q3 2021 13F
Filed Oct 29, 2021
|
29 | $501.3M |
33 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q4 2023
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | MDT MEDTRONIC PLC | $35.8M | 8.7% |
| 2 | PFE PFIZER INC | $31.5M | 7.64% |
| 3 | GILD GILEAD SCIENCES INC | $31.0M | 7.52% |
| 4 | BIIB BIOGEN INC | $26.5M | 6.42% |
| 5 | INCY INCYTE CORP | $25.0M | 6.07% |
| 6 | BMY BRISTOL-MYERS SQUIBB CO | $19.2M | 4.66% |
| 7 | GEHC GE HEALTHCARE TECHNOLOGIES I | $19.1M | 4.64% |
| 8 | CVS CVS HEALTH CORP | $17.3M | 4.2% |
| 9 | ZBH ZIMMER BIOMET HOLDINGS INC | $17.2M | 4.17% |
| 10 | CAH CARDINAL HEALTH INC | $16.6M | 4.02% |
| 11 | CNC CENTENE CORP DEL | $16.1M | 3.9% |
| 12 | THC TENET HEALTHCARE CORP | $14.6M | 3.54% |
| 13 | EW EDWARDS LIFESCIENCES CORP | $14.3M | 3.47% |
| 14 | ELV ELEVANCE HEALTH INC | $13.1M | 3.18% |
| 15 | BAX BAXTER INTL INC | $12.7M | 3.08% |
| 16 | GMED GLOBUS MED INC | $12.5M | 3.03% |
| 17 | LH LABORATORY CORP AMER HLDGS | $11.5M | 2.8% |
| 18 | BRKR BRUKER CORP | $9.4M | 2.27% |
| 19 | BMRN BIOMARIN PHARMACEUTICAL INC | $8.3M | 2.02% |
| 20 | QGEN QIAGEN NV | $8.3M | 2.01% |
Values as reported on the Q4 2023 Form 13F. Every position is in the holdings table below.